Tocqueville Asset Management L.P. Clovis Oncology, Inc. Transaction History

Tocqueville Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $158,598 - $267,192	-5,400 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $1.64 Million - $2.43 Million	-38,925 Reduced 87.82%	5,400 $246,000
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $524,004 - $708,012	-10,455 Reduced 19.09%	44,325 $2.34 Million
Q4 2017 Feb 13, 2018	SELL	$57.69 - $84.58 $1.64 Million - $2.4 Million	-28,355 Reduced 34.11%	54,780 $3.73 Million
Q3 2017 Oct 30, 2017	BUY	$67.17 - $84.81 $5.58 Million - $7.05 Million	83,135	83,135 $6.85 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.